Antibody pairs for identifying SARS-CoV-2 N protein
Request for Technology Licensing or Collaboration
Antibody pairs for identifying SARS-CoV-2 N protein
Docket Number
28A-1090916
Announcement Date
IP Status
know-how
Abstract
In this invention, we describe molecular engineering methods to enhance FRIL’s antiviral effect and decrease antigenicity, and molecular cloning of FRIL to engineer specific sites for easier enzyme cleavage.
Technological Advantages
- The antibody screening is in-vitro system which can produce multiple antibodies at the same time.
- The screening system is optimized for lateral flow devices.
- Antibodies can be further optimized if necessary.
Applications of Technology
- Lateral flow immunoassay for detecting SARS-CoV-2 N protein
- Combination of rapid test kits for upper respiratory tract infection (corona virus and influenza virus, for example).
Inventor
An-Suei Yang, Chung-Ming Yu, Chao-Ping Tung, Horng-Ru Hsu, Hung-Pin Peng, Chi-Yung Chen, Yu-Chuan Huang, Pei-Hsun Tsai, Szu-Yu Lin, Fei-Hung Hung
Antibody pairs for identifying SARS-CoV-2 N protein